NCT03664596View on ClinicalTrials.gov

Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

September 1, 2020

Study Completion Date

December 1, 2020

Conditions
Non-alcoholic Steatohepatitis
Interventions
DIETARY_SUPPLEMENT

Sublimated mare's milk

Supplement obtained through sublimation of mare milk, packed into one-dosage sachet (20g), and dissolved in a warm water (36 degrees of Celcius).

DRUG

Ursodeoxycholic Acid

Ursodeoxycholic acid in the form of 250 mg capsule.

Trial Locations (1)

010000

Medical Centre Hospital of the President's Affairs Administration, Astana

All Listed Sponsors
collaborator

Eurasia Invest Ltd.

INDUSTRY

collaborator

Ministry of Education and Science, Republic of Kazakhstan

OTHER_GOV

lead

Medical Centre Hospital of the President's Affairs Administration, Republic of Kazakhstan

OTHER_GOV

NCT03664596 - Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis | Biotech Hunter | Biotech Hunter